Healthcare Realty Trust (HR)
Real Estate · healthcare REIT · NYSE
Healthcare Realty Trust is a specialized REIT focused on the ownership and management of outpatient medical office buildings across the US.
What Healthcare Realty Trust does
Healthcare Realty Trust is a real estate investment trust (REIT) that owns, manages, and develops medical office buildings and outpatient facilities. The company focuses on properties located in the vicinity of healthcare systems to support clinical and administrative operations. Its portfolio consists primarily of multi-tenant medical office buildings concentrated in strategic markets across the United States.
Themes: healthcare infrastructure, medical office real estate, outpatient healthcare services
Fundamentals
- Price$17.19 as of 2026-10-08 close
- Market cap$5.9B as of 2026-07-27 (share count; price 2026-10-08)
- 1-year return-2.8% 2025-10-08 close $17.68 → 2026-10-08 close $17.19
- P/En/a negative earnings
- Net margin-20.8% FY2025, SEC XBRL
- ROE-5.3% FY2025, SEC XBRL
- Debt / equity1.01 as of 2026-09-03
- Revenue growth (YoY)-6.3% as of 2026-09-03
- Revenue CAGR (3y)+8.2% SEC XBRL
- Beta0.28 as of 2026-09-03
- Last reported earnings2026-07-30 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +5.3%; 1-year non-decreasing per-share dividend streak (SEC XBRL).
How HR compares in its sector
- net profit marginbottom 10% 154 covered Real Estate peers, as of 2026-09-03
- return on equitybottom 25% 158 covered Real Estate peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 155 covered Real Estate peers
- indicated dividend yieldmiddle range 140 covered Real Estate peers, as of 2026-09-03
Position among covered Real Estate companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
HR is not currently in any published Top 10 list. Its scores are below.
Top 10 score
44.3 #1024 of 1,379 scored · #49 of 87 in Real Estate
Valuation 85th (price to book 1.4) and capital return 63rd (net share count bought back over the year 4.3, consecutive years of dividend increases 1 year); weakest is profitability (12th, return on equity -5.3%).
Scores as of 8 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, HR's dividend was covered by reported results (operating-cash-flow payout 85%). This describes past coverage, not a forecast.
- Earnings payoutnot assessable earnings were not positive that year
- Operating-cash-flow payout85% dividends / operating cash flow — capital spending was not reported, so this does not subtract it
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Healthcare Realty Trust looks technically
Healthcare Realty Trust (HR) is trading 8.3% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed above its 200-day average about 276 trading days ago — a "golden cross", a bullish long-term signal. A strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 44, with sellers in control. Momentum is beaten down — its 14-day RSI (a 0–100 momentum gauge) is 28, in oversold territory (below 30). It made a new 20-day low about 2 trading days ago. It is 22.0% below its highest point of the past year.
Trend
7
| Distance from the 200-day | it is trading 8.3% below its 200-day average, the long-term trend line — a long-term downtrend | -8.3% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $18.89 | $18.89 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $18.75 | $18.75 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing low 38 calendar days ago — the swings before that are what the structure reading is measured on | 38 sessions |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 276 trading days ago — a "golden cross", a bullish long-term signal | 276 sessions |
| Trend strength (14-day ADX) | a strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 44, with sellers in control | 43.7 |
Momentum
3
| 14-day RSI | momentum is beaten down — its 14-day RSI (a 0–100 momentum gauge) is 28, in oversold territory (below 30) | 27.7 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($16.83 to $18.46) — its "stochastic" reading is 22 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 22.1 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 17 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $22.04 | $22.04 |
|---|---|---|
| From the 52-week high | it is 22.0% below its 52-week high (its highest price of the past year) | -22.0% |
| Above the 52-week low | it is 5.3% above its 52-week low (its lowest price of the past year) | +5.3% |
| Below the 52-week high | it is 22.0% below its highest point of the past year | 22.0% |
| Since a 20-day breakout | it made a new 20-day low about 2 trading days ago | 2 sessions |
| Since a 55-day breakout | it made a new 55-day low about 2 trading days ago | 2 sessions |
| All-time high | its highest closing price on record is $44.19 (set on 2007-02-08) | $44.19 |
| Given back of the 52-week move | over the past year its closes ranged ($16.34 to $21.87), and it has given back almost all of its rise from last year’s low — 85% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $18.28 to $18.45. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 84.6% |
| From the all-time high | it is 61.1% below its all-time high | -61.1% |
| Nearest price level | it is sitting right on a support level at $17.11 — a price it turned at 7 times since 2024-11-15, most recently on 2025-11-03. Since 2024-10-08 it has 5 such levels below the current price and 6 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.5% |
| All-time low | its lowest closing price on record is $12.06 (set on 2009-03-06) | $12.06 |
| Above the all-time low | it is 42.5% above its all-time low | +42.5% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are wider than usual versus its own recent 6-month history (wider than about 77% of it) | 77th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.3395 between its high and its low — about 2.0% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.3395 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $16.75 and $19.12 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $16.75 – $17.93 – $19.12 |
| Typical daily range (% of price) | its price moves about 2.0% in a typical session — among the calmest in the catalog. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.0% |
| Stretch from the 200-day average | it is trading 4.6 daily ranges below its 200-day average price (8.3% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 4.6 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.95× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a doji | 4 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 4 sessions ago |
|---|---|---|
| Since a bullish engulfing | 9 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 9 sessions ago |
Price gaps
1
| Gap at the open | it opened on 2026-10-08 0.1% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.1% |
|---|
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 10.9 percentage points (the stock lost 9.8% while the market gained 1.0%) | -10.8% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 20.5 percentage points (the stock lost 16.7% while the market gained 3.8%) | -20.5% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 18.0 percentage points (the stock lost 0.6% while the market gained 17.5%) | -18.0% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 17.7 percentage points (the stock lost 2.8% while the market gained 15.0%) | -17.8% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, its RSI momentum gauge is oversold (a beaten-down reading) — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bearish state: trading below its 200-day average, a fresh 20-day low, MACD momentum is negative, a strong downtrend, with sellers in control, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 13% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 3.5% of the share price. | -13.1% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 9% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $18.89 — a volume-weighted average of daily closes over 191 sessions, not a true tick-by-tick VWAP. | -9.0% |
|---|---|---|
| Vs the average paid since it last reported | the price is 8% below the average price paid since it last reported on 2026-07-30 (its 10-Q), so the typical buyer over that stretch is under water. That average is $18.77 — a volume-weighted average of daily closes over 50 sessions, not a true tick-by-tick VWAP. | -8.4% |
Price levels it has turned at before
HR last closed at $17.19 on 2026-10-08. Since 2024-10-08 it has turned at 5 prices below its last close and 6 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $17.11 | Support | 0.5% below the last close | turned there 7 times · 2024-11-15 to 2025-11-03 |
| $17.46 | Resistance | 1.6% above the last close | turned there five times · 2025-01-28 to 2026-01-20 |
| $16.68 | Support | 3.0% below the last close | turned there six times · 2024-11-01 to 2026-03-30 |
| $17.78 | Resistance | 3.4% above the last close | turned there twice · 2025-09-16 to 2025-12-11 |
| $16.14 | Support | 6.1% below the last close | turned there 7 times · 2025-02-12 to 2026-01-29 |
| $18.60 | Resistance | 8.2% above the last close | turned there 10 times · 2024-10-30 to 2026-08-31 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Oversold (14-day RSI below 30) · Pulled back from the 12-month high · Broke down to a new 20-day low · lagging the market · Least volatile (2% or less typical daily range) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$21.42 range $18.00 – $24.00; median $21.50
Analyst estimates, as of 2026-10-09. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for HR
- Consensus EPS estimate$0.00 next reporting period, as of 2026-10-09
- Estimate change, 30 days$0.00 from $0.00, on 2026-09-04, 35-day window
- Readings revised upward0% of 5 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Significant reliance on debt financing and exposure to interest rate fluctuations","Risk of property impairment and credit losses within the portfolio","Concentration in medical real estate, which is subject to changes in healthcare reimbursement and regulatory policies"]
What changed in the latest 10-Q
AI-assisted comparison of HR's 10-Q filed 2026-05-01 against the prior one filed 2025-10-31.
Management's Discussion & Analysis (MD&A)
- Added:
- Reference to Annual Report on Form 10-K for the year ended December 31, 2025 (in newer filing dated 2026-05-01)
- Removed:
- Reference to 'This report and other materials the Company has filed or may file with the SEC, as well as information included in oral statements or other written statements made, or to be made, by senior management of the Company, contain, or will contain, disclosures' language (older filing dated 2025-10-31)
- Reference to 'Steward Health and Prospect Medical bankruptcies' - changed to only 'Prospect Medical bankruptcy' (newer filing)
- Reference to 'Unsecured Credit Facility' - changed to 'Revolving Facility' (newer filing)
- Reference to 'recent passage of the One Big Beautiful Bill Act which is the subject of ongoing analysis' - modified wording (newer filing)
- Reworded:
- Forward-looking statements disclosure simplified: removed phrase 'This report and other materials the Company has filed or may file with the SEC, as well as information included in oral statements or other written statements made, or to be made, by senior management of the Company' and streamlined to 'This report contains disclosures' (newer filing 2026-05-01)
- Bankruptcy reference changed from 'Steward Health and Prospect Medical bankruptcies' to 'Prospect Medical bankruptcy' only (newer filing 2026-05-01)
- Credit facility terminology changed from 'Unsecured Credit Facility' to 'Revolving Facility' (newer filing 2026-05-01)
- Healthcare legislation description changed from 'recent passage of the One Big Beautiful Bill Act which is the subject of ongoing analysis' to 'the impact of the One Big Beautiful Bill Act passed during 2025 that is subject of ongoing analysis' (newer filing 2026-05-01)
- Notes:
- The newer filing text appears truncated at the end of the government regulations section, preventing full comparison of that section
- Page number differs between filings (23 vs 27), consistent with content and spacing variations
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 1 open-market sale by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 90 days · read to 2026-10-040 buys · 1 sell ($401310) — 1 selling insider
- Last 180 days · read to 2026-10-040 buys · 2 sells ($926184) — 2 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-09-08. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about HR's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Short interest (FINRA)
HR had 16,109,127 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
HR had 4.70% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 4.91 days to cover at the same settlement.
- Reported short interest (shares) 16,109,127
- Short interest (% of shares outstanding) 4.70%
- Prior settlement (shares) 16,890,491
- Reported change -4.63%
- Days to cover (reported) 4.91
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Healthpeak Properties (DOC)
- Physicians Realty Trust (DOC)
- Welltower (WELL)
- Ventas (VTR)
- Omega Healthcare Investors (OHI)
- Medical Properties Trust
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare HR vs…
Healthcare Realty Trust is found in…
Frequently asked questions
What does Healthcare Realty Trust (HR) do?
Healthcare Realty Trust is a real estate investment trust (REIT) that owns, manages, and develops medical office buildings and outpatient facilities. The company focuses on properties located in the vicinity of healthcare systems to support clinical and administrative operations. Its portfolio consists primarily of multi-tenant medical office buildings concentrated in strategic markets across the United States.
What sector is Healthcare Realty Trust (HR) in?
Healthcare Realty Trust (HR) is classified in the Real Estate sector. Its industry is healthcare REIT. It trades on NYSE.
Does HR pay a dividend?
Yes — Healthcare Realty Trust (HR) pays a dividend, with an indicated yield of about 5.26% and 1-year non-decreasing per-share dividend streak (SEC EDGAR XBRL) (market data, as of 2026-09-03). Informational only — not financial advice.
Who are Healthcare Realty Trust's (HR) competitors?
Notable peers of Healthcare Realty Trust (HR) include Healthpeak Properties, Physicians Realty Trust, Welltower, Ventas and Omega Healthcare Investors. This peer set is informational only — not financial advice.
Is Healthcare Realty Trust (HR) overbought or oversold right now?
Healthcare Realty Trust (HR) is currently in oversold territory (its 14-day RSI is 28, below 30) (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on HR come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.